Critical Roles of LncRNA-mediated Autophagy in Urologic Malignancies

Overview

Journal Front Pharmacol

Date 2024 Jun 28

PMID 38939836

Authors

Lifeng Gan

Liying Zheng

Junrong Zou

Peiyue Luo

Tao Chen

Jun Zou

Wei Li

Qi Chen

Le Cheng

Fangtao Zhang

Biao Qian

Affiliations

Soon will be listed here.

Abstract

Urologic oncology is a significant public health concern on a global scale. Recent research indicates that long chain non-coding RNAs (lncRNAs) and autophagy play crucial roles in various cancers, including urologic malignancies. This article provides a summary of the latest research findings, suggesting that lncRNA-mediated autophagy could either suppress or promote tumors in prostate, kidney, and bladder cancers. The intricate network involving different lncRNAs, target genes, and mediated signaling pathways plays a crucial role in urological malignancies by modulating the autophagic process. Dysregulated expression of lncRNAs can disrupt autophagy, leading to tumorigenesis, progression, and enhanced resistance to therapy. Consequently, targeting particular lncRNAs that control autophagy could serve as a dependable diagnostic tool and a promising prognostic biomarker in urologic oncology, while also holding potential as an effective therapeutic approach.

References

Morshed A, Paul S, Hossain A, Basak T, Hossain M, Hasan M . Baicalein as Promising Anticancer Agent: A Comprehensive Analysis on Molecular Mechanisms and Therapeutic Perspectives. Cancers (Basel). 2023; 15(7). PMC: 10093079. DOI: 10.3390/cancers15072128. View

Li N, Zhan X . Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes. EPMA J. 2020; 11(2):289-309. PMC: 7272521. DOI: 10.1007/s13167-020-00209-y. View

Prensner J, Chinnaiyan A . The emergence of lncRNAs in cancer biology. Cancer Discov. 2011; 1(5):391-407. PMC: 3215093. DOI: 10.1158/2159-8290.CD-11-0209. View

Ma X, Ren H, Zhang Y, Wang B, Ma H . LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway. Environ Toxicol. 2022; 37(12):3013-3027. DOI: 10.1002/tox.23656. View

Chen X, Lun L, Hou H, Tian R, Zhang H, Zhang Y . The Value of lncRNA HULC as a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis. Cell Physiol Biochem. 2017; 41(4):1424-1434. DOI: 10.1159/000468005. View

Beaver L, Kuintzle R, Buchanan A, Wiley M, Glasser S, Wong C . Long noncoding RNAs and sulforaphane: a target for chemoprevention and suppression of prostate cancer. J Nutr Biochem. 2017; 42:72-83. PMC: 5360475. DOI: 10.1016/j.jnutbio.2017.01.001. View

Zeng H, Zhou S, Cai W, Kang M, Zhang P . LncRNA SNHG1: role in tumorigenesis of multiple human cancers. Cancer Cell Int. 2023; 23(1):198. PMC: 10492323. DOI: 10.1186/s12935-023-03018-1. View

Xue M, Li X, Wu W, Zhang S, Wu S, Li Z . Upregulation of long non-coding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein α contributes to bladder cancer cell growth and reduced apoptosis. Oncol Rep. 2014; 31(5):1993-2000. PMC: 4020618. DOI: 10.3892/or.2014.3092. View

Meldolesi J . Exosomes and Ectosomes in Intercellular Communication. Curr Biol. 2018; 28(8):R435-R444. DOI: 10.1016/j.cub.2018.01.059. View

10.

Ulitsky I, Bartel D . lincRNAs: genomics, evolution, and mechanisms. Cell. 2013; 154(1):26-46. PMC: 3924787. DOI: 10.1016/j.cell.2013.06.020. View

11.

Lv D, Xiang Y, Yang Q, Yao J, Dong Q . Long Non-Coding RNA TUG1 Promotes Cell Proliferation and Inhibits Cell Apoptosis, Autophagy in Clear Cell Renal Cell Carcinoma via MiR-31-5p/FLOT1 Axis. Onco Targets Ther. 2020; 13:5857-5868. PMC: 7311099. DOI: 10.2147/OTT.S254634. View

12.

Ghafouri-Fard S, Shoorei H, Mohaqiq M, Majidpoor J, Moosavi M, Taheri M . Exploring the role of non-coding RNAs in autophagy. Autophagy. 2021; 18(5):949-970. PMC: 9196749. DOI: 10.1080/15548627.2021.1883881. View

13.

Choi M . Autophagy in Kidney Disease. Annu Rev Physiol. 2019; 82:297-322. DOI: 10.1146/annurev-physiol-021119-034658. View

14.

Ghafouri-Fard S, Esmaeili M, Taheri M, Samsami M . Highly upregulated in liver cancer (HULC): An update on its role in carcinogenesis. J Cell Physiol. 2020; 235(12):9071-9079. DOI: 10.1002/jcp.29765. View

15.

Yang X, Zhang Y, Fan H . Downregulation of SBF2-AS1 functions as a tumor suppressor in clear cell renal cell carcinoma by inhibiting miR-338-3p-targeted ETS1. Cancer Gene Ther. 2020; 28(7-8):813-827. DOI: 10.1038/s41417-020-0197-4. View

16.

Tay Y, Rinn J, Pandolfi P . The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014; 505(7483):344-52. PMC: 4113481. DOI: 10.1038/nature12986. View

17.

Ghafouri-Fard S, Khoshbakht T, Hussen B, Baniahmad A, Taheri M, Mokhtari M . A review on the role of PCGEM1 lncRNA in cancer. Pathol Res Pract. 2022; 240:154223. DOI: 10.1016/j.prp.2022.154223. View

18.

Lu P, Jiang Y, Xia Z . Long noncoding RNA TUG1 decreases bladder cancer chemo-sensitivity toward doxorubicin through elevating KPNA2 expression and activating the PI3K/AKT pathway via adsorbing miR-582-5p. Anticancer Drugs. 2022; 34(1):144-154. DOI: 10.1097/CAD.0000000000001393. View

19.

Cheng G, Liu D, Liang H, Yang H, Chen K, Zhang X . A cluster of long non-coding RNAs exhibit diagnostic and prognostic values in renal cell carcinoma. Aging (Albany NY). 2019; 11(21):9597-9615. PMC: 6874440. DOI: 10.18632/aging.102407. View

20.

Patergnani S, Guzzo S, Mangolini A, DellAtti L, Pinton P, Aguiari G . The induction of AMPK-dependent autophagy leads to P53 degradation and affects cell growth and migration in kidney cancer cells. Exp Cell Res. 2020; 395(1):112190. DOI: 10.1016/j.yexcr.2020.112190. View